📋About
Research grants and fellowships, MyeTRIAL Partnership, Clinical Service Excellence Programme, Peer Buddy service, Myeloma Helpline (260+ languages), Knowledge is Power awareness campaign, drug appraisal advocacy, Precursor Framework
📊Key Metrics
Multiple NHS drug approvals secured in 2025 including world-first BVD approval, benefitting thousands of myeloma patients
Key Metric 1
UK's leading myeloma charity working to prevent, treat and help people live well with myeloma through research, advocacy and patient support
Key Metric 2
Funding pioneering research, securing NHS treatment access, supporting patients and carers, and raising awareness of myeloma symptoms and precursor conditions
Key Metric 3
✅Key Outcomes
- IsaVRD quadruplet treatment approved in England, Wales and Scotland — 63% of patients still in remission after five years in trials
- Myeloma Awareness Week campaign reached over 1.6 million people with symptom awareness content
- 86 hospitals accredited through the Clinical Service Excellence Programme since 2015; helpline now accessible in over 260 languages